← All trials
NCT02378753
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2015
- Primary completion
- Nov 8, 2016
- Completion date
- Dec 5, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 8651
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- University of Sierra LeoneOverall official - principal investigator
- University of Sierra LeoneCollaborator
- Department of Health and Human ServicesCollaborator
- eHealth AfricaCollaborator
- Government of Sierra LeoneCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.